SSPharma Intermediates — CAS Index

27143-07-3 1267610-26-3 545445-44-1 536759-91-8 503614-91-3

3680-69-1 1383385-64-5 1148-11-4 5773-80-8 1029716-44-6

1187595-85-2 129488-10-4 90357-51-0 90356-78-8 17178-11-9

826-55-1 953071-73-3 1638785-15-5 1638785-17-7 1841081-72-8

17852-52-7 1236033-21-8 479633-63-1 252720-31-3 886061-26-3

103041-38-9 42288-26-6 212322-56-0 873-74-5 1307233-93-7

211915-06-9 211915-84-3 461432-23-5 21739-92-4 461432-24-6

461432-25-7 1780-26-3 915095-89-5 915095-99-7 86087-23-2

915095-85-1 112704-79-7 143782-23-4 915087-25-1 105942-08-3

291756-76-8 221615-75-4 249561-98-6 90536-66-6 330786-24-8

330792-70-6 143900-44-1 158401-00-4 2758907-91-2 1171331-39-7

2653-16-9 14192-26-8 262368-30-9 54962-75-3 2124221-12-9

218301-22-5 138564-58-6 138564-59-7 138564-60-0 144690-92-6

1016636-76-2 39856-53-0 1013916-37-4 571188-59-5 6629-04-5

107228-51-3 1211443-58-1 1211443-61-6 438056-69-0 161596-47-0

24065-33-6 446292-08-6 898543-06-1 941685-27-4 269410-08-4

762240-92-6 2033-24-1 209995-38-0 764667-65-4 486460-32-6

350-03-8 22889-78-7 636-73-7 16133-25-8 881674-56-2

Enzalutamide Abamaciclib Alectinib Apixaban Abrocitinib

Baricitinib Apalutamide Adapalene Baricitinib Belumosudil

Bicalutamide Bilastine Capivasertib Capivasertib Dabigatran

Dapagliflozin Dasatinib Empagliflozin Etoricoxib Ibrutinib

Lotinaler Nintedanib Nilotinib Oclacitinib Olaparib

Olanzapine Olmesartan Palbociclib Palbociclib / Ribociclib Resmetirom

Ribociclib Rivaroxaban Ruxolotinib Sitagliptin Imatinib

Roflumilast Vonoprazan Celecoxib Oclacitinib

Home Our Story Certificates Research & Development Infrastructure

Intermediates Contact